BICYCLE THERAPEUTICS PLC
live · Yahoo FinanceLimited buying: $45.9M bought (counted up to $5.0M); 9 distinct insiders. Holding it back: largest buyer: NG CAROLYN (Director), 17% of the dollars.
Score, not a recommendation.
partial dataAn input is missing, usually the market cap or the price history. A missing input counts as neutral in the score and is never estimated. Market cap is missing; missing inputs count as neutral in the score.
Price and insider purchases
Live chart from Yahoo Finance, loaded through this server; our daily closes when it is unavailable.
Loading price history…
How the score adds up
How each input is counted →| Input | Strength | Points |
|---|---|---|
| $45.9M bought (counted up to $5.0M)The dollars the insiders bought, a purchase reported jointly counted once, counted from $131. Each tenfold adds 12.4 points, up to $5.0M; more adds nothing. The bar is empty at $10.0K and full at $5.0M. | 100% | +57 |
| 9 distinct insidersHow many different insiders bought. Each extra insider adds less than the one before (the points follow the log of the count: 4.3 per doubling). The bar is full at 10 insiders. | 95% | +13 |
| No CEO among the buyersWhether the chief executive is among the buyers: 10.6 points when yes. | 0% | +0 |
| Stock 0% below its 1-year highHow far the stock had fallen from its highest close of the past year, at the close before the buying. Every 10% of fall adds 1.9 points. A fall beyond 30% adds nothing more. The bar is full at a 30% fall. | 0% | +0 |
| 2 days from first to last purchaseDays between the first and the last purchase. Each day takes off 0.11 points: buying close together keeps more. The bar is empty at 60 days. | 97% | +0 |
| Routine or plan purchases: 0% of the dollars | 100% | +0 |
| Largest buyer: NG CAROLYN (Director), 17% of the dollars | 93% | -2 |
| Match scoreA score from 0 to 100 worked out from the dollars bought, the number of insiders, whether a CEO bought, how far the stock had fallen, how spread out the purchases were and how much came from one buyer. Its weights were calibrated on past clusters. It is the default ranking of the lists and it decides which clusters get the AI review. It describes the buying; it is not a forecast. | 68 | |
| Pipeline flagsPoints taken off because the filings themselves show this buying was an offering, a plan or a 10b5-1 programme. Used only when there is no AI review; from Form 4 footnotes, 8-K filings and prices. (IPO or offering) | -14 | |
| Insider ScoreThe number from 0 to 100 shown on each cluster and used to rank the lists. By default it is the match score, plus the points of the AI review when there is one. It describes the buying; it is not a forecast or a recommendation. | 54 | |
Why are they buying?
No explanation has been generated for this cluster. The filings in the table below are the primary evidence.
| Date | InsiderAn officer or director of a company, or an owner of more than 10% of its shares. The law requires them to report their trades in the company's stock to the SEC. | Role | Shares | Price | Value | Flags | Filing |
|---|---|---|---|---|---|---|---|
| 2019-05-27 | NG CAROLYN history of NG CAROLYN's purchases | Director | 571,429 | $14.00 | $8.0M | SEC filing for NG CAROLYN (opens in a new tab) | |
| 2019-05-28 | BINGHAM KATE history of BINGHAM KATE's purchases | Director | 385,715 | $14.00 avg | $5.4M | ||
| 2019-05-28 | BINGHAM KATE | 377,732 | $14.00 | $5.3M | SEC filing for BINGHAM KATE (opens in a new tab) | ||
| 2019-05-28 | BINGHAM KATE | 7,983 | $14.00 | $111.8K | SEC filing for BINGHAM KATE (opens in a new tab) | ||
| 2019-05-28 | SV LIFE SCIENCES FUND V LP history of SV LIFE SCIENCES FUND V LP's purchases | 10% owner | 385,715 | $14.00 avg | $5.4M | ||
| 2019-05-28 | SV LIFE SCIENCES FUND V LP | 7,983 | $14.00 | $111.8K | SEC filing for SV LIFE SCIENCES FUND V LP (opens in a new tab) | ||
| 2019-05-28 | SV LIFE SCIENCES FUND V LP | 377,732 | $14.00 | $5.3M | SEC filing for SV LIFE SCIENCES FUND V LP (opens in a new tab) | ||
| 2019-05-28 | GLAXOSMITHKLINE PLC history of GLAXOSMITHKLINE PLC's purchases | Director | 385,714 | $14.00 | $5.4M | SEC filing for GLAXOSMITHKLINE PLC (opens in a new tab) | |
| 2019-05-28 | HARLAND DEBORAH history of HARLAND DEBORAH's purchases | Director | 385,714 | $14.00 | $5.4M | SEC filing for HARLAND DEBORAH (opens in a new tab) | |
| 2019-05-28 | TYBOURNE CAPITAL MANAGEMENT (HK) LTD history of TYBOURNE CAPITAL MANAGEMENT (HK) LTD's purchases | 10% owner | 364,286 | $14.00 | $5.1M | SEC filing for TYBOURNE CAPITAL MANAGEMENT (HK) LTD (opens in a new tab) | |
| 2019-05-28 | Anstey Michael history of Anstey Michael's purchases | Director | 314,286 | $14.00 | $4.4M | SEC filing for Anstey Michael (opens in a new tab) | |
| 2019-05-29 | Cambridge Innovation Capital (Jersey) Ltd history of Cambridge Innovation Capital (Jersey) Ltd's purchases | 10% owner | 314,286 | $14.00 | $4.4M | SEC filing for Cambridge Innovation Capital (Jersey) Ltd (opens in a new tab) | |
| 2019-05-28 | NOVARTIS AG history of NOVARTIS AG's purchases | 10% owner | 168,630 | $14.00 | $2.4M | SEC filing for NOVARTIS AG (opens in a new tab) | |
| Total | $45.9M | ||||||
What happened next
A buying runPurchases at one company with no pause longer than the cluster rule allows. A long pause ends the run, so one company can have several. ends after a pause in the buying, so one company can have several. Returns are the stock's return minus its benchmarkThe index a stock's return is compared with: a small-cap index for small companies, a large-cap index otherwise. (IWM for small companies, SPY otherwise), from the first open after the buying run became a cluster. Past results, not a forecast.
After this buying run became a cluster, vs benchmark: 21 days -24.4% (-16.8% raw)63 days -44.7% (-38.3% raw)126 days -40.8% (-27.6% raw)